Ligand validation:8REO

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 8REO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8REO_FDA_C_303	96%	64%	0.056	0.966	0.64	0.75	-	1	0	0	100%	1
8REO_FDA_D_303	95%	64%	0.06	0.965	0.6	0.76	-	2	1	0	100%	1
8REO_FDA_B_305	95%	66%	0.058	0.962	0.61	0.71	-	-	0	0	100%	1
8REO_FDA_A_303	91%	64%	0.067	0.952	0.62	0.76	-	2	0	0	100%	1
8REQ_FDA_D_303	93%	60%	0.07	0.963	0.64	0.87	-	4	1	0	100%	0.9
8REN_FDA_B_304	89%	64%	0.067	0.947	0.61	0.78	-	1	0	0	100%	1
4KAT_FDA_C_301	56%	7%	0.143	0.913	3.25	1.67	18	12	4	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3UKF_FDA_B_600	100%	10%	0.026	0.995	2.22	2.05	19	19	0	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
4MOR_FDA_B_801	100%	15%	0.037	0.989	1.83	1.96	12	19	1	0	100%	1
4OPC_FDA_A_501	100%	64%	0.038	0.986	0.6	0.76	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.